Table 2.

The in vivo inhibition activity of compounds 2, 5 and 6 against H₂₂ liver cancer.

Sample (T/C, %)	Dose (µmol/kg)	Weight of tumor (g)	Ratio of tumor inhibition
Control	0	1.63±0.31	0
5-Fu	150	0.59±0.19	64.07
2	150	0.95±0.30	41.64
5	150	0.89±0.53	45.17
6	150	1.26±0.54	22.85